Drug-eluting balloons for de Novo coronary artery disease: A Meta-Analysis of Angiographic and Clinical Data

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 7, 2013, Pages 1021-1030

  Zhang, Tuo ^a   Sun, Shiqun ^a   Shen, Linghong ^a   He, Ben ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

de novo coronary artery disease; drug eluting balloon; percutaneous coronary intervention

Indexed keywords

PACLITAXEL;

ANGIOCARDIOGRAPHY; ARTICLE; BALLOON; BARE METAL STENT; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; HUMAN; INCIDENCE; META ANALYSIS;

DE NOVO CORONARY ARTERY DISEASE; DRUG-ELUTING BALLOON; PERCUTANEOUS CORONARY INTERVENTION;

CARDIAC CATHETERIZATION; CARDIAC CATHETERS; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; EQUIPMENT DESIGN; HUMANS; METALS; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 84888135231     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25022     Document Type: Article

References (22)

1. De Labriolle A, Pakala R, Bonello L, Lemesle G, Scheinowitz M, Waksman R,. Paclitaxel-eluting balloon: From bench to bed. Catheter Cardiovasc Interv 2009; 73: 643-652.
2. Barbash IM, Waksman R,. Current status, challenges and future directions of drug-eluting balloons. Future Cardiol 2011; 7: 765-774.
3. Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, Fusaro M, Ott I, Ibrahim T, Hausleiter J, Valina C, Pache J, Laugwitz KL, Massberg S, Kastrati A,. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): A randomised, open-label trial. Lancet 2012;doi: 10.1016/S0140-6736 (12) 61964-3.
4. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U,. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006; 355: 2113-2124.
5. Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Degenhardt R, Scheller B,. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2010; 99: 165-174.
6. Fanggiday JC, Stella PR, Guyomi SH, Doevendans PA,. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: The DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry. Catheter Cardiovasc Interv 2008; 71: 629-635.
7. Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, Marchese A, Tespili M, Presbitero P, Sgueglia GA, Buffoli F, Tamburino C, Varbella F, Menozzi A,. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: The BELLO (Balloon Elution and Late Loss Optimization) Study. J Am Coll Cardiol 2012; 60: 2473-2480.
8. Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Van Belle E, Wildbergh T, Politi L, Doevendans PA, Sangiorgi GM, Stella PR,. First results of the DEB-AMI (Drug Eluting Balloon in Acute ST-Segment Elevation Myocardial Infarction) Trial: A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. J Am Coll Cardiol 2012; 59: 2327-2337.
9. Ali RM, Degenhardt R, Zambahari R, Tresukosol D, Ahmad WA, Kamar HH, Kui-Hian S, Ong TK, bin Ismail O, bin Elis S, Udychalerm W, Ackermann H, Boxberger M, Unverdorben M,. Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention 2011; 7 Suppl K: K83-92.
10. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH,. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58: e44-e122.
11. Zhang T, Shen LH, Hu LH, He B,. Statins for the prevention of contrast-induced nephropathy: A systematic review and meta-analysis. Am J Nephrol 2011; 33: 344-351.
12. Zhang T, Shen L, Hu L, He B,. Optimal duration of dual-antiplatelet therapy following drug-eluting stent implantation: A meta-analysis. J Clin Pharmacol 2013; 53: 345-351.
13. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D,. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol 2009; 62: e1-34.
14. Stella PR, Belkacemi A, Dubois C, Nathoe H, Dens J, Naber C, Adriaenssens T, van Belle E, Doevendans P, Agostoni P,. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: Six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheter Cardiovasc Interv 2012; 80: 1138-1146.
15. Liistro F, Angioli P, Grotti S, Ducci K, Falsini G, Bolognese L,. Predilatation with drug eluting balloon followed by bare metal stent implantation versus drug eluting stent in the treatment of simple de-novo native coronary stenosis. J Am Coll Cardiol 2011; 58: B5.
16. Hamm CW, Cremers B, Moellmann H, Mobius-Winkler S, Zeymer U, Vrolix M, Schneider S, Dietz U, Bohm M, Scheller B,. PEPCAD III: A randomised trial comparing a paclitaxel-coated balloon/stent system with a sirolimus eluting stent. Circulation 2009; 120: 2157.
17. Cortese B, Micheli A, Picchi A, Coppolaro A, Bandinelli L, Severi S, Limbruno U,. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 2010; 96: 1291-1296.
18. Loh JP, Waksman R,. Paclitaxel drug-coated balloons: A review of current status and emerging applications in native coronary artery de novo lesions. JACC Cardiovasc Interv 2012; 5: 1001-1012.
19. Joner M, Byrne RA, Lapointe JM, Radke PW, Bayer G, Steigerwald K, Wittchow E,. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis. Thromb Haemost 2011; 105: 864-872.
20. Mehilli J, Dibra A, Kastrati A, Pache J, Dirschinger J, Schomig A,. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 2006; 27: 260-266.
21. Waksman R, Pakala R,. Drug-eluting balloon: The comeback kid? Circ Cardiovasc Interv 2009; 2: 352-358.
22. Riley RD, Lambert PC, Abo-Zaid G,. Meta-analysis of individual participant data: Rationale, conduct, and reporting. BMJ 2010; 340: c221.